Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Rika Goda"'
Autor:
Takeshi Onda, Hitomi Hayashi, Hiroko Mashiba, Iwao Nakamura, Akira Masuda, Daichi Nagai, Eiji Ichimura, Hirofumi Yokoyama, Rika Goda
Publikováno v:
International Journal of Nanomedicine
Iwao Nakamura, Eiji Ichimura, Rika Goda, Hitomi Hayashi, Hiroko Mashiba, Daichi Nagai, Hirofumi Yokoyama, Takeshi Onda, Akira Masuda Nanomedicine Group, Pharmaceutical Research Laboratories, Nippon Kayaku Co., Ltd., Tokyo, Japan Abstract: In our prev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f58635e692dc4ed29ea396d12a62685c
https://doi.org/10.2147/ijn.s114356
https://doi.org/10.2147/ijn.s114356
Autor:
Takayuki Hirai, Tetsuya Hamaguchi, Taito Esaki, Hirofumi Mukai, Yoshihiro Nambu, Ken Kato, Rika Goda, Shouzou Ohsumi, Yasuo Hozomi, Yasuhiro Matsumura, Nobuaki Matsubara
Publikováno v:
Investigational New Drugs
Previous studies have established the rationale for NK105, a nanomicellar formulation of paclitaxel, administered every 3 weeks. The aim of this phase I study was to determine the recommended dose and pharmacokinetics of weekly administered NK105. NK
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1f0ce23969cd7712beac572632165de
https://pubmed.ncbi.nlm.nih.gov/27595901
https://pubmed.ncbi.nlm.nih.gov/27595901
Autor:
Yasushi Matsuzaki, Mikio Doi, Eiji Ichimura, Kiyohiro Nishikawa, Arihiro Tomura, Daichi Nagai, Rika Goda
Publikováno v:
Journal of Gastroenterology. 41:231-239
Flutamide, a nonsteroidal antiandrogen used for treatment of prostate cancer, causes a temporary increase in transaminase and in some cases severe liver dysfunction. It is dominantly metabolized by cytochrome P450 (CYP) 1A2 into 2-hydroxyflutamide (O
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e66bef58b7cb37e45b56ba75e9bf9ee
https://doi.org/10.1007/s00535-005-1749-y
https://doi.org/10.1007/s00535-005-1749-y
Publikováno v:
Drug Metabolism and Pharmacokinetics. 13:229-236
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::559d62b56c1646fc9d75549474b19e6f
https://doi.org/10.2133/dmpk.13.229
https://doi.org/10.2133/dmpk.13.229
Publikováno v:
Journal of the Mass Spectrometry Society of Japan. 45:367-375
Cytochrome P450 (Cyt. P450) is capable of metabolizing a wide range of endogenous and xenobiotic compounds. The metabolism of testosterone has been used to probe into Cyt. P450 isoenzyme activities of rat liver preparations in vitro. Then we studied
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9215dee2865981841e878626a7f6c142
https://doi.org/10.5702/massspec.45.367
https://doi.org/10.5702/massspec.45.367
Autor:
Rika Goda, Kiyohiro Nishikawa, Kiyoshi Nagata, Yoshio Aizawa, Yuji Akiyama, Isao Ikemoto, Yasushi Yamazoe, Daichi Nagai
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals. 34(5)
Flutamide (2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]-propanamide), a nonsteroidal antiandrogen, is used in the treatment of prostate cancer but is occasionally associated with hepatic dysfunction. In the present study, the metabolism of flutamid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6f0e13ec577d641e2e628e8c0126534
https://pubmed.ncbi.nlm.nih.gov/16507648
https://pubmed.ncbi.nlm.nih.gov/16507648
Autor:
Iwao Nakamura, Eiji Ichimura, Rika Goda, Hitomi Hayashi, Hiroko Mashiba, Daichi Nagai, Hirofumi Yokoyama, Takeshi Onda, Akira Masuda
Publikováno v:
International Journal of Nanomedicine; Feb2017, Vol. 12, p1293-1304, 12p